Cargando…
A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
OBJECTIVE: Brivaracetam (BRV) and levetiracetam (LEV) are antiepileptic drugs that bind synaptic vesicle glycoprotein 2A (SV2A). In vitro and in vivo animal studies suggest faster brain penetration and SV2A occupancy (SO) after dosing with BRV than LEV. We evaluated human brain penetration and SO ti...
Autores principales: | Finnema, Sjoerd J., Rossano, Samantha, Naganawa, Mika, Henry, Shannan, Gao, Hong, Pracitto, Richard, Maguire, Ralph P., Mercier, Joël, Kervyn, Sophie, Nicolas, Jean‐Marie, Klitgaard, Henrik, DeBruyn, Steven, Otoul, Christian, Martin, Paul, Muglia, Pierandrea, Matuskey, David, Nabulsi, Nabeel B., Huang, Yiyun, Kaminski, Rafal M., Hannestad, Jonas, Stockis, Armel, Carson, Richard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532410/ https://www.ncbi.nlm.nih.gov/pubmed/30924924 http://dx.doi.org/10.1111/epi.14701 |
Ejemplares similares
-
Drug characteristics derived from kinetic modeling: combined (11)C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A
por: Naganawa, Mika, et al.
Publicado: (2022) -
Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet
por: Otoul, Christian, et al.
Publicado: (2016) -
Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
por: Schoemaker, Rik, et al.
Publicado: (2017) -
Extrapolation of a Brivaracetam Exposure–Response Model from Adults to Children with Focal Seizures
por: Schoemaker, Rik, et al.
Publicado: (2017) -
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
por: Matuskey, David, et al.
Publicado: (2020)